drug eluting stents - Globe Thesis

Keyword [drug eluting stents] Result: 101 - 120 \| Page: 6 of 7
101.	Drug diffusion and structural design criteria for conventional and auxetic drug-eluting stents
102.	Rapamycin and Adiponectin in Vascular Smooth Muscle Cells: Implications in the Development of Drug-Eluting Stents
103.	The Association Between Plasma Homocysteine And In-stent Restenosis In Patients With Coronary Heart Disease Treated With Drug-eluting Stents
104.	Effects Of PIP Targeting LOX-1 Eluting Stents On In-stent Restenosis In Rat Abdominal Aorta Stenting Models
105.	Duration Of Dual Antiplatelet Therapy After Second-genenration Drug-eluting Stent Implantation In Patients With Diabetes Mellitus
106.	Meta-analysis Of The Effectiveness And Safety Of Short-term(1-3 Month) Vs Standard(12 Month) Dual Antiplatelet Therapy After New Generation Drug-eluting Stents Implantion
107.	Clinical Outcomes Of Very Short Term Dual Antiplatelet Therapy In Patients With Or Without Diabetes Undergoing Second-generation Drug-eluting Stents: A Meta-analysis
108.	Predictors Of In-stent Restenosis In Patient Complicating With Type 2 Diabetes Mellitus Within 2 Years After Drug-eluting Stents Implantation
109.	Efficacy And Safety Of Dual Antiplatelet Therapy After Percutaneous Coronary Drug-eluting Stenting:A Network Meta-analysis
110.	Impact Of High-density Lipoprotein Cholesterol Level On Short-term Healing Response Following Implantation Of Drug-eluting Stent
111.	Comparison Of NeoVas Bioabsorbable Scaffolds Vs.XIENCE V Drug-eluting Stents In Patients With Coronary Artery Disease
112.	Meta Analysis Of Short-term Dual Antiplatelet Therapy After PCI
113.	Meta Analysis Of Dual Antiplatelet Therapy ?3 Months And Dual Antiplatelet Therapy 12-Months After Second-generation Drug-eluting Stents Implantation
114.	Comparison Of Drug-Coated Balloons Alone With Provisional Side-Branch Stenting Strategy For De-Novo True Coronary Bifurcation Lesions
115.	Effectiveness And Safety Of Different Strategies In The Management Of Coronary Stent Restenosis
116.	Comparison Of Clinical Outcomes Between Second-and First-generation Drug-eluting Stents In Patients With Chronic Total Occlusion Lesion:A Meta-analysis
117.	Polymer-free Versus Second-generation Durable Polymer Drug-eluting Stents In Coronary Artery Disease Patients: A Meta-analysis
118.	The Long-term Efficacy And Safety Of New Drug Eluting Stents: A Meta-analysis
119.	Comparison Of Drug-eluting Stents Versus Drug-coated Balloons For The Treatment Of In-stent Restenosis
120.	Efficacy And Safety Of Short-term Dual Antiplatelet Therapy After New-generation Drug-eluting Stents Implantation In East Asians: A Systematic Review And A Meta-analysis Of Randomized Clinical Trials
<<First <Prev Next> Last>> Jump to